ReviewInternational journal of cardiology2020

Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib.

Anand Prakash Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.